These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8044313)

  • 1. Viral inactivation in platelet concentrates.
    Dodd RY
    Transfus Clin Biol; 1994; 1(3):181-6. PubMed ID: 8044313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light.
    Lin L; Hanson CV; Alter HJ; Jauvin V; Bernard KA; Murthy KK; Metzel P; Corash L
    Transfusion; 2005 Apr; 45(4):580-90. PubMed ID: 15819680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoralen-mediated photodecontamination of platelet concentrates: inactivation of cell-free and cell-associated forms of human immunodeficiency virus and assessment of platelet function in vivo.
    Margolis-Nunno H; Bardossy L; Robinson R; Ben-Hur E; Horowitz B; Blajchman MA
    Transfusion; 1997 Sep; 37(9):889-95. PubMed ID: 9308633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of 8-methoxypsoralen and long wavelength ultraviolet radiation for decontamination of platelet concentrates.
    Corash L; Lin L; Wiesehahn G
    Blood Cells; 1992; 18(1):57-73; discussion 74. PubMed ID: 1617193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma.
    Wollowitz S
    Semin Hematol; 2001 Oct; 38(4 Suppl 11):4-11. PubMed ID: 11727280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA.
    Grass JA; Hei DJ; Metchette K; Cimino GD; Wiesehahn GP; Corash L; Lin L
    Blood; 1998 Mar; 91(6):2180-8. PubMed ID: 9490707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two pathogen reduction technologies--methylene blue plus light and shortwave ultraviolet light--effectively inactivate hepatitis C virus in blood products.
    Steinmann E; Gravemann U; Friesland M; Doerrbecker J; Müller TH; Pietschmann T; Seltsam A
    Transfusion; 2013 May; 53(5):1010-8. PubMed ID: 22905868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus inactivation in blood components by photoactive phenothiazine dyes.
    Wagner SJ
    Transfus Med Rev; 2002 Jan; 16(1):61-6. PubMed ID: 11788930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function.
    Knutson F; Alfonso R; Dupuis K; Mayaudon V; Lin L; Corash L; Högman CF
    Vox Sang; 2000; 78(4):209-16. PubMed ID: 10895093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light.
    Lin L; Cook DN; Wiesehahn GP; Alfonso R; Behrman B; Cimino GD; Corten L; Damonte PB; Dikeman R; Dupuis K; Fang YM; Hanson CV; Hearst JE; Lin CY; Londe HF; Metchette K; Nerio AT; Pu JT; Reames AA; Rheinschmidt M; Tessman J; Isaacs ST; Wollowitz S; Corash L
    Transfusion; 1997 Apr; 37(4):423-35. PubMed ID: 9111281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing virus inactivation and retention of platelet properties following treatment with aminomethyltrimethylpsoralen and ultraviolet A light.
    Moroff G; Wagner S; Benade L; Dodd RY
    Blood Cells; 1992; 18(1):43-54; discussion 54-6. PubMed ID: 1617192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quencher-enhanced specificity of psoralen-photosensitized virus inactivation in platelet concentrates.
    Margolis-Nunno H; Robinson R; Ben-Hur E; Horowitz B
    Transfusion; 1994 Sep; 34(9):802-10. PubMed ID: 8091471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of residual 4'-aminomethyl-4,5',8-trimethylpsoralen and mutagenicity testing following psoralen plus UVA treatment of platelet suspensions.
    Wagner SJ; White R; Wolf L; Chapman J; Robinette D; Lawlor TE; Dodd RY
    Photochem Photobiol; 1993 May; 57(5):819-24. PubMed ID: 8337254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photochemical inactivation of cell-associated human immunodeficiency virus in platelet concentrates.
    Lin L; Londe H; Hanson CV; Wiesehahn G; Isaacs S; Cimino G; Corash L
    Blood; 1993 Jul; 82(1):292-7. PubMed ID: 8324230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro photochemical inactivation of cell-associated human T-cell leukemia virus Type I and II in human platelet concentrates and plasma by use of amotosalen.
    Jauvin V; Alfonso RD; Guillemain B; Dupuis K; Fleury HJ
    Transfusion; 2005 Jul; 45(7):1151-9. PubMed ID: 15987361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of viruses in platelet suspensions that retain their in vitro characteristics: comparison of psoralen-ultraviolet A and merocyanine 540-visible light methods.
    Dodd RY; Moroff G; Wagner S; Dabay MH; Dorfman E; George V; Ribeiro A; Shumaker J; Benade LE
    Transfusion; 1991; 31(6):483-90. PubMed ID: 1853439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria.
    Lin L; Dikeman R; Molini B; Lukehart SA; Lane R; Dupuis K; Metzel P; Corash L
    Transfusion; 2004 Oct; 44(10):1496-504. PubMed ID: 15383024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New technologies for the inactivation of infectious pathogens in cellular blood components and the development of platelet substitutes.
    Corash L
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):549-63. PubMed ID: 11102276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogen inactivation of blood components: current status and introduction of an approach using riboflavin as a photosensitizer.
    Corbin F
    Int J Hematol; 2002 Aug; 76 Suppl 2():253-7. PubMed ID: 12430933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates.
    Corash L
    Vox Sang; 1998; 74 Suppl 2():173-6. PubMed ID: 9704443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.